These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 27398734)

  • 1. Interactions of hyperhomocysteinemia and T cell immunity in causation of hypertension.
    Veeranki S; Gandhapudi SK; Tyagi SC
    Can J Physiol Pharmacol; 2017 Mar; 95(3):239-246. PubMed ID: 27398734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic determinants of plasma total homocysteine.
    Gellekink H; den Heijer M; Heil SG; Blom HJ
    Semin Vasc Med; 2005 May; 5(2):98-109. PubMed ID: 16047263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinemia independently associated with the risk of hypertension: a cross-sectional study from rural China.
    Li Z; Guo X; Chen S; Zheng L; Yang H; Sun G; Yu S; Li W; Zhou L; Wang J; Hu W; Sun Y
    J Hum Hypertens; 2016 Aug; 30(8):508-12. PubMed ID: 26155996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NRP1 regulates HMGB1 in vascular endothelial cells under high homocysteine condition.
    Ma Y; Zhang Z; Chen R; Shi R; Zeng P; Chen R; Leng Y; Chen AF
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1039-H1046. PubMed ID: 30767669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of hyperhomocysteinemia on insulin resistance in patients with H-type hypertension.
    Zhang Y; Wang G; Liu J; Xu Y
    Clin Exp Hypertens; 2018; 40(1):28-31. PubMed ID: 29172743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations.
    de Bree A; van der Put NM; Mennen LI; Verschuren WM; Blom HJ; Galan P; Bates CJ; Herrmann W; Ullrich M; Dierkes J; Westphal S; Bouter LM; Heine RJ; Stehouwer CD; Dekker JM; Nijpels GN; Araújo F; Cunha-Ribeiro LM; Refsum H; Vollset S; Nygard O; Ueland PM
    Eur J Clin Nutr; 2005 Apr; 59(4):480-8. PubMed ID: 15674310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Hyperhomocysteinemia and Hyperuricemia in Pathogenesis of Atherosclerosis.
    Zhao J; Chen H; Liu N; Chen J; Gu Y; Chen J; Yang K
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2695-2699. PubMed ID: 28986198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updating the relationship between hyperhomocysteinemia lowering therapy and cardiovascular events.
    Cheng X
    Cardiovasc Ther; 2013 Aug; 31(4):e19-26. PubMed ID: 23082962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Homocysteine Levels Are Associated With the Metabolic Syndrome and Cardiovascular Events in Hypertensive Patients.
    Catena C; Colussi G; Nait F; Capobianco F; Sechi LA
    Am J Hypertens; 2015 Jul; 28(7):943-50. PubMed ID: 25498997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoregulatory effects of homocysteine on cardiovascular diseases.
    Dai J; Wang X
    Sheng Li Xue Bao; 2007 Oct; 59(5):585-92. PubMed ID: 17940698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation between plasma homocysteine level and cardiovascular risk factors in cerebral ischemia.
    Huang CW; Chen TH; Lin HS; Tseng YL; Lai SL; Chen WH; Chen SS; Liu JS
    Acta Neurol Taiwan; 2007 Jun; 16(2):81-5. PubMed ID: 17685131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Homocysteine: a casual link with heart failure?].
    Vizzardi E; Bonadei I; Zanini G; Fiorina C; Raddino R; Dei Cas L
    Minerva Med; 2009 Oct; 100(5):421-7. PubMed ID: 19910894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes of hyperhomocysteinemia and its pathological significance.
    Kim J; Kim H; Roh H; Kwon Y
    Arch Pharm Res; 2018 Apr; 41(4):372-383. PubMed ID: 29552692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association Between Tea Consumption and Hyperhomocysteine in Chinese Hypertensive Patients.
    Zhu J; Wang W; Xiong Y; Cooper RS; Du Raza-Arvizu R; Cao G; Wang Y; Ji P; Bian R; Xu J
    Am J Hypertens; 2019 Jan; 32(2):209-215. PubMed ID: 30379988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine Triggers Inflammatory Responses in Macrophages through Inhibiting CSE-H2S Signaling via DNA Hypermethylation of CSE Promoter.
    Li JJ; Li Q; Du HP; Wang YL; You SJ; Wang F; Xu XS; Cheng J; Cao YJ; Liu CF; Hu LF
    Int J Mol Sci; 2015 Jun; 16(6):12560-77. PubMed ID: 26047341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms.
    Zhou J; Austin RC
    Biofactors; 2009; 35(2):120-9. PubMed ID: 19449439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine and cardiovascular disease: a review of the evidence.
    Wierzbicki AS
    Diab Vasc Dis Res; 2007 Jun; 4(2):143-50. PubMed ID: 17654449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential role of homocysteine mediated DNA methylation and associated epigenetic changes in abdominal aortic aneurysm formation.
    Krishna SM; Dear A; Craig JM; Norman PE; Golledge J
    Atherosclerosis; 2013 Jun; 228(2):295-305. PubMed ID: 23497786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.